‘It’s a Version of an Experiment’: What We Heard This Week


“It’s a version of an experiment. You have to really treat that, in my mind, as an experiment and get people’s informed consent.” — Arthur Caplan, PhD, of NYU Grossman School of Medicine, on changing COVID-19 vaccine dosing from what was tested in the registration trials.

“Hard to argue with results from 40,000 patients.” — Lauren Sorce, PhD, RN, of Northwestern University in Chicago, discussing a study showing lower mortality and shorter hospital stay for children with sepsis treated with bundled care.

“It’s really supply and demand here. We’ve got high demand and limited supply.” — Bonnie Litvack, MD, president of the Medical Society of the State of New York, on the shortage of COVID-19 vaccines for community doctors.

“The fact that you can actually assess the [ER] function in the body was amazing.” — Farrokh Dehdashti, MD, of Washington University in St. Louis, commenting on a study of PET imaging to predict response to endocrine therapy for breast cancer.

“There is a desperate need for improved healthcare and safety measures for people with chronic pain taking prescribed opioids so they are not subjected to unethical and dangerous practices.” — Beth Darnall, PhD, director of the Stanford University Pain Relief Innovations Lab, about Medicare patients who had their long-term opioid therapy stopped abruptly.

“The drug overdose crisis in the U.S. continues, and mortality involving psychoactive stimulant drugs is rising.” — Joshua Black, PhD, of Denver Health’s Rocky Mountain Poison and Drug Safety division in Colorado, about cocaine-, methamphetamine-, and amphetamine-involved death rates doubling every 4 years since 2010.

Products You May Like

Articles You May Like

Study reveals key mechanism by which exercise promotes immunity, strengthens bones
FDA approves Nulibry to reduce risk of death caused by rare genetic, metabolic disorder
My loved one needs therapy, what do I do next?
Baby talk: preventative counselling for new parents
Mobile phone app could help curb rabies threat in African cities

Leave a Reply

Your email address will not be published. Required fields are marked *